Follow
Daniel T Vader
Daniel T Vader
Postdoctoral Researcher, University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Impact of the COVID-19 pandemic on treatment patterns for patients with metastatic solid cancer in the United States
RB Parikh, SU Takvorian, D Vader, E Paul Wileyto, AS Clark, DJ Lee, ...
JNCI: Journal of the National Cancer Institute 114 (4), 571-578, 2022
112022
Hospital-acquired Clostridioides difficile infection among patients at an urban safety-net hospital in Philadelphia: Demographics, neighborhood deprivation, and the …
DT Vader, C Weldie, SL Welles, MA Kutzler, ND Goldstein
Infection Control & Hospital Epidemiology, 7, 2020
72020
A predictive model for hepatitis B infection among high‐risk adults using a community‐based sample in greater Philadelphia
C Freeland, D Vader, C Cohen, B George
Journal of Viral Hepatitis 27 (12), 1319-1325, 2020
52020
Hepatitis B birth dose effects on childhood immunization in the US
DT Vader, BK Lee, AA Evans
American Journal of Preventive Medicine 58 (2), 208-215, 2020
52020
Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer.
SU Takvorian, RB Parikh, D Vader, EP Wileyto, AS Clark, DJ Lee, G Goyal, ...
Journal of Clinical Oncology 39 (15_suppl), 1528-1528, 2021
22021
Two Ways To Measure Interpersonal Synchrony in Dance/Movement Therapy: Comparing Accelerometer Data with Observational Data
N Prakash, A Ramakrishnan, DT Vader, N Beardall, RH Moore, M Shim, ...
2024
Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation
DT Vader, R Mamtani, Y Li, SD Griffith, GS Calip, RA Hubbard
Epidemiology 34 (4), 520-530, 2023
2023
Impact of label restriction on checkpoint-inhibitor use in bladder cancer and changes in mortality
DT Vader, RB Parikh, H Li, K Imai, RA Hubbard, R Mamtani
JNCI Cancer Spectrum 6 (4), pkac050, 2022
2022
Impact of FDA label change on immunotherapy for metastatic urothelial cancer (mUC) and subsequent changes in mortality.
D Vader, RB Parikh, H Li, K Imai, RA Hubbard, R Mamtani
Journal of Clinical Oncology 40 (6_suppl), 459-459, 2022
2022
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
RB Parikh, SU Takvorian, D Vader, EP Wileyto, AS Clark, DJ Lee, G Goyal, ...
medRxiv, 2021.09. 22.21263964, 2021
2021
Re-estimating prevalence of hepatitis B virus immunity among adults in the United States: self-reported vaccination, immunologic markers, and bias correction
DT Vader, C Cohen, ND Goldstein, BK Lee, H Quick, AA Evans
medRxiv, 2021.07. 20.21260652, 2021
2021
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer (preprint)
RB Parikh, SU Takvorian, D Vader, EP Wileyto, AS Clark, DJ Lee, G Goyal, ...
2021
Predictive model for hepatitis b virus using multiple imputation from a community-based sample of individuals in greater Philadelphia
C Freeland, D Vader, C Cohen, B George
APHA's 2020 VIRTUAL Annual Meeting and Expo (Oct. 24-28), 2020
2020
Misclassification and biased estimates of adult hepatitis B immune prevalence in the United States
DT Vader
Drexel University, 2020
2020
Examining the Impact of Dance/Movement Therapy on Empathy, Peer Relationships, and Cultural Self Efficacy in Middle School: A Mixed Methods Study
N Prakash, S Goodill, S Sood, D Vader, R Moore, N Beardall, S Minjung
Movement Therapy on Empathy, Peer Relationships, and Cultural Self Efficacy …, 0
The system can't perform the operation now. Try again later.
Articles 1–15